SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-052846
Filing Date
2020-04-29
Accepted
2020-04-29 08:06:05
Documents
13
Period of Report
2020-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2016840d2_8k.htm   iXBRL 8-K 43055
2 EXHBIT 99.1 tm2016840d2_ex99-1.htm EX-99.1 14790
  Complete submission text file 0001104659-20-052846.txt   243027

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adap-20200429.xsd EX-101.SCH 3195
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adap-20200429_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adap-20200429_pre.xml EX-101.PRE 22716
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2016840d2_8k_htm.xml XML 3671
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 20827492
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences